Navigation Links
New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
Date:10/23/2008

Masimo's Commercial Exhibit Draws More Than 2,500 Conference Attendees

IRVINE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that 13 new independent and objective clinical studies presented at the American Society of Anesthesiology (ASA) Annual Meeting in Orlando, Fla., October 19-21, 2008, found Masimo SET(R) and Masimo Rainbow SET(R) technologies to be crucial in providing clinicians with an early indication of their patients' deteriorating health status in numerous clinical settings, which may allow earlier intervention and prevention of adverse clinical outcomes.

In addition, Masimo's commercial exhibit attracted over 2,500 anesthesiologists from the U.S. and around the world. Anesthesiologists visiting the commercial exhibit marveled at Masimo noninvasive hemoglobin (SpHb(TM)), the first-and-only technology capable of continuously monitoring hemoglobin status. Continuous monitoring of anemic status with Masimo SpHb may allow clinicians to make earlier and better treatment decisions, such as detecting blood loss earlier to initiate more timely transfusions in some patients and avoiding unnecessary blood transfusions in others.

Select Clinical Study Highlights

Continuous Pulse Ox Impacts Early Detection of Physiological Abnormalities in Post-Surgical Patients(1), a clinical evaluation led by Dr. George Blike at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, compared clinical data, patient outcomes and nursing satisfaction before and after implementation of Masimo Patient SafetyNet(TM) -- a remote monitoring and wireless clinician notification system -- on a 36-bed post-surgical care unit. Findings during the three-month evaluation -- covering 2,587 total patient days -- showed an 80 percent decrease in distress codes and rescue activations, and a 50 percent decrease in ICU transfers for Masimo Pati
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/...) (the "Company"), a global biopharmaceutical comp...ay announced that the U.S. Food and Drug Administr... the Company,s PI3K/Akt pathway inhibitor compound...psed/refractory multiple myeloma. Keryx Biopharmac...
(Date:12/1/2009)... Dr. Kerry Solomon announced ... has launched his redesigned website at www.DrKer...sulting Group. Dr. Solomon is a proven LASIK, len...n professionally recognized for his substantial co.... He is a member of Trusted LASIK Surgeons, which...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Rep... report is available in its catalogue: ,, Emer...rket dynamics and the changing healthcare and regu....com/p0165658/Emerging-Clinical-Trial-Locations---...althcare-and-regulatory-environment.html ,, Ov...
(Date:12/1/2009)... , SHANGHAI, Dec. 1 /PRNewswire-Asia/ --...of ShangPharma, a leading China-based Contract Res...winner of the 2009 Deloitte,Technology Fast 50 Chi... high,tech companies in China. The award is a test...nue growth from 2006 to 2008. , The resul...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...ietary Products Division of Par Pharmaceutical wit...ortive Care, WOODCLIFF LAKE, N.J., Sept. 28 /PRNe...Inc. (NYSE: PRX ) today announced its commitment,...gs, through the,establishment and introduction of ...y pharmaceuticals division. Strativa Pharmaceutica...
...ORD, Mass., Sept. 28 Cynosure, Inc.,(Nasdaq: CYN...ad array of,light-based aesthetic treatment system...t the Leerink Swann & Company/MEDACorp Aesthetics ...mothy Baker will discuss Cynosure,s business,outlo...n a presentation,beginning at 2:10 p.m. ET Wednesd...
...IDGE, Mass., Sept. 28 Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...ounced a strategic restructuring. As part of the,r... agreement with Novartis,Pharma AG related to Tyze...,will discontinue all development, manufacturing a...
Other Biology Technology:Introducing Strativa Pharmaceuticals 2Introducing Strativa Pharmaceuticals 3Introducing Strativa Pharmaceuticals 4Introducing Strativa Pharmaceuticals 5Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 2Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 3Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs 4
(Date:12/1/2009)...Broadly speaking, ants have two different feeding ... "carnivorous," meaning that they are generalist p...ing on their remains. Some, however, are "herbivo...ts; rather, the bulk of their diets consist of pla...cky fluids produced by plants to attract ants, cal...
(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...
(Date:12/1/2009)...Yehezkel Ben-Ari, winner of the 2009 Inserm Grand ...d its commitment to paying tribute to outstanding,...s. By honouring talents, Inserm intends to,demons...ved in today,s biological, medical and,health res...nd women who carry out and,drive this research ea...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor 13555 1Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor 13555 2Service Corporation International Declares Quarterly Cash Dividend 54485 1Service Corporation International Declares Quarterly Cash Dividend 54485 2Service Corporation International Declares Quarterly Cash Dividend 54485 3Exercise May Help in Leukemia Recovery 54483 1Exercise May Help in Leukemia Recovery 54483 2
...light green light," winners are able to stop, and ...mrades. New research reveals that a similar race g...he big winner. , "The research provides new insigh...lps explain the impulsivity of people with attenti...uthor Jeffrey Schall, E. Bronson Professor of Neur...
...ssor of Medicine and Pharmacology at the Universit...ne has studied about 265 twin pairs over the past ...scoveries. , "By studying many traits and genes, w..." he said. , Studying genetic variations in twi...e heritable, or passed down through human DNA, ver...
...ing system in the brain has just been shown to be ...p; Science University study found. , The signaling...iming to reverse meth’s adverse health effects as ... , Working in the recently opened Program in Che...artment of Physiology and Pharmacology, scientists...
Other Biology News:Racing neurons control whether we stop or go 2Racing neurons control whether we stop or go 3Twin studies reveal genetic components leading to cardiac and kidney disease 2Twin studies reveal genetic components leading to cardiac and kidney disease 3OHSU lab finds meth receptor that could lead to therapy 2OHSU lab finds meth receptor that could lead to therapy 3
Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
GIBCO Donor Calf Serum from Invitrogen
...agicMark XP Western Protein Standards are specific...cular weight estimation directly on western blots....e, allowing direct visualization with the same ant...t protein on the blots. Colorimetric, chemilumines...
Genetic Mapping of Disease Genes from Promega
Biology Products: